Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon gamma-1b for macular edema in RCD and ESCS
NCT02338973Phase 2Terminated
- Sponsor
- National Eye Institute
- Start
- Jan 2015
- Primary completion
- Jun 2018
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon gamma-1b in macular edema, retinoschisis, sponsored by National Eye Institute. Started Jan 2015; status: terminated.
02
Drugs
interferon gamma-1b
03
Conditions
macular edemaretinoschisis
Beyond the preview
Go deeper on NCT02338973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02338973.